Fisher Scientific to Buy Oxoid and Dharmacon for US$410 M
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 46 (Table of Contents)
Published: 4 Apr-2004
DOI: 10.3833/pdr.v2004.i46.818 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Fisher Scientific entered into two separate acquisition agreements with Dharmacon and Oxoid for a total deal value of US$410 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018